These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30516454)

  • 1. Reducing Door-to-Needle Times for Ischaemic Stroke to a Median of 30 Minutes at a Community Hospital.
    Kamal N; Shand E; Swanson R; Hill MD; Jeerakathil T; Imoukhuede O; Heinrichs I; Bakker J; Stoyberg C; Fowler L; Duckett S; Holsworth S; Mann B; Valaire S; Bestard J
    Can J Neurol Sci; 2019 Jan; 46(1):51-56. PubMed ID: 30516454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Door-to-Needle Times for Acute Ischemic Stroke: Effect of Rapid Patient Registration, Moving Directly to Computed Tomography, and Giving Alteplase at the Computed Tomography Scanner.
    Kamal N; Holodinsky JK; Stephenson C; Kashayp D; Demchuk AM; Hill MD; Vilneff RL; Bugbee E; Zerna C; Newcommon N; Lang E; Knox D; Smith EE
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
    Sauser K; Levine DA; Nickles AV; Reeves MJ
    JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017.
    Tong X; Wiltz JL; George MG; Odom EC; Coleman King SM; Chang T; Yin X; ; Merritt RK
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004981. PubMed ID: 30557047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
    Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of an emergency medicine pharmacist on door to needle alteplase time and patient outcomes in acute ischemic stroke.
    Barbour J; Hushen P; Newman GC; Vidal J
    Am J Emerg Med; 2022 Jan; 51():358-362. PubMed ID: 34823191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Bedside Preparation in Reducing "Door-to-Needle" Tissue-Type Plasminogen Activator (Alteplase) Administration Times and Association with Patient Outcomes.
    Lebahn KK; Waybright RA; Ngorsuraches S; Johnson TJ
    S D Med; 2018 Sep; 71(9):416-421. PubMed ID: 30308121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving door-to-needle times: a single center validation of the target stroke hypothesis.
    Ruff IM; Ali SF; Goldstein JN; Lev M; Copen WA; McIntyre J; Rost NS; Schwamm LH
    Stroke; 2014 Feb; 45(2):504-8. PubMed ID: 24399372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Learning Collaboratives Produce Rapid and Sustainable Improvements in Stroke Thrombolysis Times.
    Prabhakaran S; Lee J; O'Neill K
    Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):585-92. PubMed ID: 27625405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Telestroke Program Improves Thrombolysis for Acute Stroke Across 21 Hospitals of an Integrated Healthcare System.
    Nguyen-Huynh MN; Klingman JG; Avins AL; Rao VA; Eaton A; Bhopale S; Kim AC; Morehouse JW; Flint AC;
    Stroke; 2018 Jan; 49(1):133-139. PubMed ID: 29247142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in thrombolytic therapy administration in acute stroke with feedback.
    Ghrooda E; Alcock S; Jackson AC
    Can J Neurol Sci; 2012 Nov; 39(6):789-92. PubMed ID: 23041399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke.
    Xian Y; Smith EE; Zhao X; Peterson ED; Olson DM; Hernandez AF; Bhatt DL; Saver JL; Schwamm LH; Fonarow GC
    Stroke; 2014 May; 45(5):1387-95. PubMed ID: 24713527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with Low National Institutes of Health Stroke Scale Scores Have Longer Door-to-Needle Times: Analysis of a Telestroke Network.
    Bhatt A; Lesko A; Lucas L; Kansara A; Baraban E
    J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):2253-8. PubMed ID: 27266620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal sustainability of guideline based door-to-needle times for intravenous thrombolysis for acute ischemic stroke.
    Raina A; Trivedi M; Kate M; Kumar L; Erat Sreedharan S; Sylaja PN
    J Clin Neurosci; 2020 Apr; 74():164-167. PubMed ID: 32094070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Door-to-Needle Delays in Minor Stroke: A Causal Inference Approach.
    Rostanski SK; Shahn Z; Elkind MSV; Liberman AL; Marshall RS; Stillman JI; Williams O; Willey JZ
    Stroke; 2017 Jul; 48(7):1980-1982. PubMed ID: 28536170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CODE FAST: a quality improvement initiative to reduce door-to-needle times.
    Busby L; Owada K; Dhungana S; Zimmermann S; Coppola V; Ruban R; Horn C; Rochestie D; Khaldi A; Hormes JT; Gupta R
    J Neurointerv Surg; 2016 Jul; 8(7):661-4. PubMed ID: 26089402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Local Tailoring on Acute Stroke Care in 21 Disparate Emergency Departments: A Prospective Stepped Wedge Type III Hybrid Effectiveness-Implementation Study.
    McKee KE; Knighton AJ; Veale K; Martinez J; McCann C; Anderson JW; Wolfe D; Blackburn R; McKasson M; Bardsley T; Ofori-Atta B; Greene TH; Hoesch R; Püttgen HA; Srivastava R
    Circ Cardiovasc Qual Outcomes; 2024 May; 17(5):e010477. PubMed ID: 38567507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phased changes in strategies can reduce delay of intravenous thrombolysis administration to 15 min.
    Itabashi R; Shigehatake Y; Yazawa Y; Endo K; Saito T; Fukuma K; Furui E; Mori E
    J Neurol Sci; 2019 Aug; 403():59-64. PubMed ID: 31226551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.